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ABSTRACT
Telomerase, the essential enzyme that maintains
telomere length, contains two core components,
TERT and TR. Early studies in yeast and mouse
showed that loss of telomerase leads to phenotypes
only after several generations, due to telomere
shortening. However, recent studies have sug-
gested additional roles for telomerase components
in transcription and the response to DNA damage.
To examine these potential telomere length
maintenance-independent roles of telomerase
components, we examined first generation mTR
 / 
and mTERT
 /  mice with long telomeres. We used
gene expression profiling and found no genes that
were differentially expressed in mTR
 /  G1 mice and
mTERT
 /  G1 mice compared with wild-type mice.
We also compared the response to DNA damage
in mTR
 / G1 and mTERT
 /  G1 mouse embryonic
fibroblasts, and found no increase in the response
to DNA damage in the absence of either telomerase
component compared to wild-type. We conclude
that, under physiologic conditions, neither mTR
nor mTERT acts as a transcription factor or plays
a role in the DNA damage response.
INTRODUCTION
The telomerase enzyme is essential for telomere length
maintenance; it catalyzes the addition of telomeric
repeats onto telomeres (1). When telomerase is absent or
deﬁcient, telomeres shorten with each cell division (2–4).
When telomeres become critically short, they induce a
DNA damage response and cells senesce or undergo
apoptosis (5–7). Thus, telomerase is required for the
long-term growth of cells. The core components of
telomerase are conserved in all eukaryotes; the reverse
transcriptase component TERT is the catalytic protein
subunit that carries out telomere repeat addition (8).
The essential telomerase RNA component TR is needed
for both enzyme activity and to provide the template for
the telomeric repeats that are synthesized (9,10). In
addition to TERT and TR, diﬀerent species have addi-
tional species-speciﬁc telomerase components.
Experiments in both yeast and mouse cells have shown
that deletion of telomerase results in loss of cell division
capacity only after telomeres become short. In yeast,
deletion of either the TERT component, EST2, or the
TR component, TLC1, has no phenotype in the ﬁrst few
generations, but results in decreased growth potential after
an increased number of cell divisions (11,12). A similar
delayed phenotype is seen in mouse; the deletion of
either mouse telomerase component, mTERT or mTR,
shows no phenotype in the ﬁrst few generations when
telomeres are long (4,13). However, after four to six
generations of interbreeding, short telomeres lead to loss
of cell division capacity and subsequent loss of tissue
renewal in tissues of high turnover (14,15). Similar
phenotypic delay in the response to loss of telomerase
has been described in Caenorhabditis elegans (16) and
Arabidopsis thaliana (17) TERT mutants, again with
ﬁrst-generation telomerase-null mutants being pheno-
typically normal. Thus, across phyla, the role of telo-
merase in telomere length maintenance is conserved, as
is the eﬀect of short telomeres on cell division capacity.
Although short telomeres limit cell division, recent
studies have suggested that, in addition to their role in
telomerase activity, TERT and TR may have cellular
functions that are independent of telomere elongation.
The acute knock-down of TR using either siRNAs or
ribozymes has been reported to rapidly reduce cancer
cell growth and to induce a set of glycolytic genes
(18–20). Acute knock-down of the TERT component
with siRNAs was reported to alter histone modiﬁcation
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aﬀect hematopoiesis in zebraﬁsh (22). siRNA studies are
known to have oﬀ-target eﬀects that result in phenotypes
unrelated to the gene targeted (23). In addition to these
knock-down studies, a number of groups have concluded
from overexpression of TERT that this protein may
have functions outside of its role in telomere elongation.
TERT overexpression was reported to protect against
cell death (24), perhaps by interfering with p53-mediated
apoptosis (25). Overexpression of TERT was also
reported to rapidly induce growth-promoting genes (26),
activate the Myc and Wnt pathways (27) and stimulate
hair follicle stem cell proliferation (28). Overexpression
studies are one way to approach an understanding of
gene function; however, they need to be interpreted in
the context of other experiments that take alternative
approaches (29). Overexpression, by design, generates a
hypermorph that has an excess of the given activity.
Further, in some cases, overexpression can result in a
neomorph that inadvertently displays a new phenotype
not associated with the original gene (30). This may be
due to inappropriate processing of high-level over-
expressed proteins (31) or inappropriate oligomerization
of overexpressed proteins with other cellular proteins (32)
that aﬀects downstream targets. Given these caveats with
both siRNA and overexpression, we wanted to assess the
role of the loss of these two telomerase components in a
controlled genetic setting.
As telomerase mutations are associated with human
disease (33), we wanted to carefully examine what
role telomerase might play independent of telomere
length maintenance. We employed a well-deﬁned genetic
system, gene deletion in mice, to examine the eﬀects of loss
of telomerase components. Mice make an excellent model
system for understanding telomeres and telomerase.
Telomeres shorten progressively in both human and
mouse cells (2,4,34) and the cellular response to short
telomeres is conserved (7,35,36). Finally, the disease
phenotypes seen in mice with telomere dysfunction faith-
fully replicate human disease (15,37). We took advantage
of the fact that the C57BL/6J mouse strain has long
telomeres. Deletion of telomerase components in this
genetic background eventually leads to telomere shorten-
ing. However, telomeres do not become critically short
until after three to four generations of interbreeding
the telomerase-null mice. This allowed us to use the ﬁrst-
generation telomerase-null mice, mTR
 /  G1, and
independently, mTERT
 /  G1, to separate the telomere
length eﬀects from any eﬀect that is due to the acute loss
of the telomerase components. We examined gene expres-
sion proﬁles and compared the mTR
 /  G1 mice and
mTERT
 /  G1 mice with each other and with wild-
type mice. Since not all functions of the DNA damage
response are mediated through transcriptional changes,
we also analyzed the DNA damage response in mTR
 / 
G1 and mTERT
 /  G1 mouse embryonic ﬁbroblasts
(MEFs). We found that in these ﬁrst-generation
telomerase-null animals, when telomeres are long, there
were no measurable eﬀects in either transcriptional





 /  mice were generated as previously described (4).
mTERT
 /  mice were obtained from Dr. Lea Harrington
(13). First-generation (G1) mTR
 /  and mTERT
 /  mice
were derived by intercrossing mTR
+/  and mTERT
+/ 
heterozygotes, respectively. Both strains were extensively
backcrossed onto the C57BL/6J genetic background and
the heterozygotes were maintained by breeding hetero-
zygotes to wild-type to avoid haploinsuﬃciency causing
telomere shortening.
Isolation and growth of MEFs
MEFs were isolated using a modiﬁed version of the
published protocol (4). Brieﬂy, embryos from day
E12.5–E14.5 were isolated from crosses between either
mTR
+/  or mTERT
+/  C57BL/6J mice. The embryos
were minced and partially digested in 0.25% trypsin
(Gibco) for 30min at 4 C, followed by a 5-min incubation
at 37 C. After centrifugation, cells were plated in 10-cm
plates containing DMEM (Gibco) supplemented with
10% FBS (Gibco), 1X PSF (Gibco) and 1X Normocin
(InvivoGen). MEFs were incubated at 37 C until conﬂu-
ent, and passaged according to the 3T3 protocol (38).
Cells were treated with 5mM camptothecin (Sigma) for
4h or 5Gy gamma rays using a cesium irradiator
(Nordion Gammacell 40 Exactor). In all experiments,
MEFs at  80% conﬂuency were treated at P5 and
harvested using 0.05% trypsin (Gibco).
RNA isolation, microarray hybridization and analysis
Livers from age- (1.5–3 months) and sex-matched (male)
wild-type, mTR
 /  G1 and mTERT
 /  G1 C57BL/6J
mice were homogenized in 15ml TRIzol reagent
(Invitrogen) using a dounce homogenizor. RNA was
extracted following the TRIzol protocol. In brief, the
liver homogenates were extracted with chloroform,
followed by 2-propanol precipitation and a 75% ethanol
wash. Pellets were resuspended and incubated in a DNase
I (Promega)/RNase inhibitor (New England BioLabs)
cocktail, followed by a ﬁnal phenol/chloroform extrac-
tion. RNA was precipitated with 100% ethanol,
resuspended in DEPC water and cleaned-up using the
RNeasy kit (Qiagen). For RNA isolation from MEFs a
modiﬁed protocol was used. Following the 75% ethanol
wash, an in-column DNase digestion using the RNeasy kit
(Qiagen) was performed prior to the clean-up step. MEFs
were derived from embryos from day E12.5–14.5. RNA
samples (1mg) from three biological replicates were sent
for hybridization on Mouse Gene 1.0 ST Arrays
(Aﬀymetrix) at the Johns Hopkins HiT Center Microarray
Facility. To avoid any genetic background eﬀect, knock-
out mice and MEFs were matched to wild-type mice and
MEFs derived from the same parents (i.e. mTR
 /  G1
and mTR WT, mTERT
 /  G1 and mTERT WT). Due
to mouse availability, the liver samples were processed in
two batches. The ﬁrst batch contained one biological
replicate for a wild-type/mTERT
 /  G1 and wild-type/
mTR
 /  G1 pair. The remaining samples were processed
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were adjusted for batch eﬀect with the R package
ComBat, using the non-parametric empirical Bayes
method [http://statistics.byu.edu/johnson/ComBat/; (39)].
Gene expression was analyzed using volcano plots and
heat maps, which were generated and analyzed with the
Spotﬁre software (TIBCO). Raw data have been deposited
at the NCBI Gene Expression Omnibus (GEO) repository
(GSE16731).
Quantitative RT-PCR
Total RNA (2mg) from mTERT
 /  G1, mTR
 /  G1 and
wild-type MEFs was reverse transcribed using random
hexamers and Superscript III reverse transcriptase
(Invitrogen), following the manufacturer’s instructions.
Quantitative RT-PCR was performed for mTERT and
mTR using a CFX96 thermocycler (Bio-Rad). Each
qRT-PCR reaction contained 1  SYBR Green
Supermix and 5mM of each primer. Roughly, 5ng
cDNA were ampliﬁed per reaction. The expression in
each sample was normalized to HPRT. The cycling
conditions for mTR were as follows: 5min at 95 C; 15s
at 95 C, 30s at 68 C, 45s at 72 C, 10s at 82 C (35 cycles);
3min at 72 C. For each cycle, ﬂuorescence readings
were performed at the 82 C step, to avoid generation of
primer dimers. For mTERT, we followed the cycling
conditions and primer sequences described elsewhere





A-30. To assess for genomic DNA contamination, in
each run we included a control in which no reverse trans-
criptase was added ( RT). All samples did not have
signiﬁcant DNA contamination, as ﬂuorescent intensities
were not above background levels. Three diﬀerent samples
for each genotype were run in triplicate and the
normalized average was reported.
Western blot
For whole-cell lysates (WCLs), MEFs were harvested after
treatment and washed twice in cold PBS. Pellets were
resuspended in 1  SDS sample buﬀer (1  Tris–Cl/
SDS pH 6.8 (0.5M Tris–Cl, 0.4% SDS), 0.05% glycerol,
0.04% SDS, 0.002% bromophenol blue, 0.5% 2-merca-
ptoethanol), boiled at 100 C for 5min and chilled on ice
for 3min. After centrifugation, WCLs (15ml) were
fractionated on sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS–PAGE; 4–15% Tris–HCl, Bio-
Rad), and transferred onto 0.2-mm PVDF membranes
(Millipore). Blocking (2h at 4 C), and multiplexed
primary antibody incubation (overnight at 4 C) were per-
formed in 1% casein/0.1% Tween-20. Primary antibodies
were as follows: rabbit phospho-p53 (Ser 15) (Cell
Signaling), rabbit anti-g-H2AX (Ser 139) (Abcam) and
mouse anti-b-actin (Abcam). After incubation with sec-
ondary antibodies conjugated to near-infrared dyes
(IRDye 680 anti-mouse and 800 anti-rabbit, LI-COR),
blots were scanned on a two-channel near-infrared
Odyssey scanner (LI-COR). Band intensities were quan-
tiﬁed using the Odyssey software (LI-COR), normalized
to b-actin levels and expressed as arbitrary units.
Experiments were performed in three individual replicates.
Immunoﬂuorescence
MEFs at  80% conﬂuence were cultured, treated and
processed on two-well chamber slides (Nunc Lab-Tek
II). Brieﬂy, cells were washed twice with PBS and ﬁxed
in 4% formaldehyde. Fixed cells were blocked (2h at
room temperature) and incubated with primary antibody
(overnight at 4 C) using 10% normal goat serum/0.1%
Triton X-100. Primary antibodies were as follows: rabbit
anti-g-H2AX (Ser 139) (Abcam), and rabbit anti-
phospho-53BP1 (Ser 1778) (Cell Signaling). Secondary
antibody incubation was performed for 2h at room tem-
perature using an Alexa ﬂuor 488-conjugated secondary
antibody (Invitrogen) and 1  DAPI nucleic-acid stain
(Invitrogen). Slides were analyzed on an Axioskop ﬂuo-
rescence microscope (Zeiss), at 25  magniﬁcation. For
quantitation, 100 cells were scored and classiﬁed into 0,
<10 and >10 categories, according to the number of foci.
Cells with >10 nuclear foci were considered to be under-
going a strong DNA damage response.
Cell proliferation assay
Cell proliferation was determined using the Click-iT
TM
EdU cell proliferation assay kit (Invitrogen), which relies
on a copper-catalyzed reaction between the alkyne-
containing nucleoside analog EdU and the Alexa Fluor
488-conjugated azide. Brieﬂy, MEFs were plated and
treated in two-well chamber slides. EdU was added imme-
diately after treatment and cells were incubated for 16h at
37 C, to allow cells to undergo a full DNA replication
cycle. Cells were ﬁxed in 3.7% formaldehyde and
permeabilized with 0.5% Trixon X-100. Cells were
washed with 3% BSA and S-phase cells were detected
with the Click-iT
TM reaction cocktail for 30min. Slides
were washed, stained with Hoechst nucleic-acid stain
and analyzed on an Axioskop ﬂuorescence microscope
(Zeiss). For each slide, 100 MEFs were scored and classi-
ﬁed as EdU-positive or -negative.
Statistical analysis
For the microarray analysis, the Spotﬁre software
(TIBCO) was used to calculate P-values using a two-way
analysis of variance (ANOVA) test. Statistical signiﬁcance
for qRT-PCR and the functional DNA damage
experiments was calculated with Microsoft Excel’s statis-
tical analysis package, using a paired Student’s t-test.
A P-value below a threshold of 0.05 was considered
statistically signiﬁcant.
RESULTS
Gene expression proﬁles of mTERT
–/– and mTR
–/– G1
mice are similar to wild-type
To test the consequences of the loss of each of the telo-
merase components, mTERT and mTR, we examined
62 Nucleic AcidsResearch, 2010,Vol. 38,No. 1transcriptional proﬁles from wild-type, mTERT
–/– G1 and
mTR
–/– G1 mice. As mentioned above, ﬁrst-generation
C57BL/6J mTR
–/– G1 and mTERT
–/– G1 mice have
long telomeres, and no phenotypes are seen in these
telomerase-null mice until telomeres become short after
interbreeding for three to six generations (4,13,14). By
comparing wild-type with mTERT
–/– G1 and mTR
–/–
G1 mice, we can separate a telomere eﬀect from any
telomere length maintenance-independent eﬀects of
mTERT or mTR deletion. We analyzed samples from
three independent mice for each genotype. To control
for potential genetic variation, for each matched set of
mTR
–/– and wild-type or mTERT
–/– and wild-type
samples, the wild-type mice were progeny from the same
parents as the knock-outs.
We isolated liver RNA from age- and sex-matched wild-
type, mTERT
–/– G1 and mTR
–/– G1 mice, and hybridized
it to Mouse Gene 1.0 ST microarrays from Aﬀymetrix.
We compared whole-genome transcriptional proﬁles in
the mTERT
–/– G1 and wild-type, and the mTR
–/– G1
and wild-type data sets separately, using volcano plots
and heat maps (Figure 1). Volcano plots represent gene
expression levels according to the fold change and statis-
tical signiﬁcance. The horizontal axis represents the
impact of telomerase absence on transcript abundance,
expressed as the fold change between the two experimental
groups, on a Log2 scale. The vertical axis represents the
statistical reliability of the fold change, expressed as a
P-value between samples, on a negative Log10 scale. Of
the genes that showed signiﬁcant levels of expression
(P<0.05) that we could analyze, we found none whose
levels were either increased or decreased at least 2-fold
when comparing either mTR
–/– G1 and wild-type or
mTERT
–/– G1 and wild-type mice (Figure 1A and B).
We next used heat maps generated by hierarchical cluster-
ing of gene expression levels to determine if the knock-
out mice were diﬀerent from the wild-type mice. We found
that knock-out and wild-type samples clustered randomly,
indicating that gene expression levels were similar in
all mice (Figure 1C and D). These experiments indicate
that mTERT
–/– G1 and mTR
–/– G1 mice have similar
transcriptional proﬁles compared to their wild-type
counterparts.
As described in the ‘Introduction’ section, recent studies
have concluded that mTERT may play telomere length
maintenance-independent roles in cell proliferation,
DNA damage response and in developmental pathways,
such as the Wnt pathway (26–28,41). To examine these
pathways speciﬁcally, we analyzed the RNA expression
levels of genes involved in the DNA damage response,
apoptosis, cell cycle and the proliferation-promoting
Wnt, Erbb (EGF) and MAPK pathways. We analyzed
each pathway independently by selecting all genes
involved in the pathway and highlighting them against
our whole-genome data using both volcano plots and
heat maps. We found no signiﬁcant diﬀerences in the
level of gene expression for any of these pathways in
mTERT
–/– G1 versus wild-type or mTR
–/– G1 versus
wild-type mice (Figure 1E–H and Supplementary Figure
S2; data not shown). Finally, we compared whole-genome
and pathway-speciﬁc expression patterns between
mTERT
–/– G1 and mTR
–/– G1 mice, as well as between
the corresponding wild-type samples. Again, we found no
signiﬁcant up- or down-regulation in the gene expression
in either of these comparisons (Supplementary Figure S3,
data not shown).
It has been suggested that the failure to observe
phenotypic consequences of telomerase loss in ﬁrst-
generation mice may be due to a compensatory pathway
masking the eﬀects of the loss of telomerase components
in the mTR
–/– and mTERT
–/– mice (27,41). Genetic com-
pensation is a well-established phenomenon in which one
or a set of genes can compensate for the loss of a gene, so
that no phenotype is seen when that gene is not functional.
The presence of paralogs and redundant genes in
organisms is thought to exemplify this need for potential
compensation (42). In well-established cases of genetic
compensation, transcriptional upregulation of the genes
that are compensating is seen (43). To determine
whether such compensation might occur in early cell
divisions after the loss of TR or TERT, we examined
gene expression proﬁles in MEFs derived from hetero-
zygous mTR
+/– and mTERT
+/– crosses. These MEFs
represent cells from early embryonic stages that have
just experienced the loss of mTR or mTERT, and as
such would allow us to see any transcriptional upregula-
tion that may compensate for the recent loss of these
telomerase components. We found no signiﬁcant diﬀer-
ences in the transcriptional proﬁles between mTR
–/– G1
and wild-type or mTERT
–/– G1 and wild-type MEFs for
any genes in the Wnt, DNA damage or apoptosis
pathways (Supplementary Figures S4 and S5, and data
not shown). Taken together, our liver and MEF data
are consistent and support the conclusion that mTERT
and mTR do not regulate gene expression levels.
We also examined the array data speciﬁcally for
proteins that are associated with telomerase. We did not
ﬁnd a change in the levels of mTERT or the accessory
components Nop10, Nhp2 or dyskerin when one compo-
nent was knocked out (Supplementary Figure S1 and
Table S1; data not shown). As telomerase RNA might
not be ampliﬁed under conditions set to ﬁnd mRNAs, to
examine the level of mTR and mTERT in the two diﬀerent
knock-outs, we used quantitative RT-PCR to directly
measure changes in both mTERT and mTR in wild-type
and knock-out MEFs. We found that mTR was not
detected in the mTR
–/– G1 MEFs and mTERT was not
detected in the mTERT
–/– G1 MEFs, as expected.
mTERT was present at comparable levels both in the
wild-type and mTR
–/– G1 samples. We observed a slight
( 1.5-fold, P=0.028) decrease in mTR transcript in the
mTERT
–/– G1 samples, suggesting that the absence of
mTERT might aﬀect the stability of the telomerase
RNA (Supplementary Figure S1 and Table S1).
mTERT
–/– and mTR
–/– cells do not show a diﬀerence in
DNA damage response induction compared to wild-type
Changes in gene expression levels might be expected if
telomerase components play a direct role in transcription;
however, some phenotypes might be due to functional
changes that do not involve transcriptional changes.
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Figure 1. Whole genome and DNA damage response-speciﬁc transcriptional proﬁles of mTERT
–/– G1 and mTR
–/– G1 mice are similar to wild-type.
RNA expression in three diﬀerent mice for each genotype was examined and transcriptional proﬁles were compared to wild-type. Volcano plots show
the P-value for correlation of the three replicates on the y-axis and the fold change between genotypes on the x-axis. Values above the horizontal red
line at Y=1.3 are considered statistically signiﬁcant (P<0.05). The vertical red lines mark the threshold for 2-fold up- or down-regulation. Genes to
the right and left of these lines are considered to be up- or down-regulated, respectively. Heat maps represent the level of gene expression across
samples and the hierarchical clustering of these. (A and B) Volcano plots of whole-genome transcriptional proﬁles of mTERT
–/– G1 and mTR
–/– G1
mice compared to wild-type. (C and D) Heat maps and clustering analysis of mTERT
–/– G1 and mTR
–/– G1 mice compared to wild-type. (E and F)
Volcano plots of DNA damage response-speciﬁc transcriptional proﬁles of mTERT
–/– G1 and mTR
–/– G1 mice compared to wild-type. DNA
damage response genes are highlighted in black against whole genome volcano plots. (G and H) Heat maps and clustering analysis of DNA damage
response gene expression of mTERT
–/– G1 and mTR
–/– G1 mice compared to wild-type. Blue represents low signal values, yellow represents high
signal values and black represents the mid-range.
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maintenance-independent role of mTR and mTERT in
DNA damage, we used a sensitive functional assay using
mTR
–/– G1, mTERT
–/– G1 and wild-type MEFs. Three
independent early-passage MEF cultures of each genotype
were treated with two diﬀerent DNA-damaging agents,
camptothecin and gamma rays, to induce a DNA
damage response. Camptothecin is a topoisomerase I
inhibitor that generates double-strand breaks (DSBs)
during DNA replication (44). Gamma rays act directly
on DNA, inducing DSBs in the sugar-phosphate
backbone. In each cell line, we monitored p53 and
H2AX (g-H2AX) phosphorylation in response to DNA
damage as examples of well-characterized damage
responses (45,46). The phosphorylation levels were moni-
tored with phospho-speciﬁc antibodies on western blots,
using b-actin as an internal loading control. We also
measured the accumulation of g-H2AX and phospho-
53BP1 (47) in DNA damage-induced foci using
immunoﬂuorescence. Finally, we monitored the rate of
cell proliferation in response to both camptothecin and
gamma irradiation.
Upon DNA damage induction with 5mM campto-
thecin, the level of phospho-p53 and g-H2AX increased
signiﬁcantly in wild-type, mTERT
–/– G1 and mTR
–/–
G1 MEFs, in all three replicate cell lines (Figure 2, see
ﬁgure legend for P-values). However, there was no signif-
icant diﬀerence in the phosphorylation levels between
wild-type and mTERT
–/– G1 or mTR
–/– G1 MEFs
(Figure 2), under both untreated [dimethyl sulfoxide
(DMSO)] and treated [camptothecin (CPT)] conditions.
As one exception, we did observe a small change in the
phosphorylation levels of H2AX in mTR
–/– G1 MEFs
(Figure 2D). Interestingly, the levels of g-H2AX were
slightly lower in the knock-out cells, opposite of what
has been reported (21).
To further examine the DNA damage response, we
examined damage-induced foci that accumulate in cells
repairing DNA damage (48). We monitored the induction
of g-H2AX and phospho-53BP1 foci by immunoﬂuores-
cence. Treatment with camptothecin generated a signiﬁ-
cant accumulation of g-H2AX- and phospho-53BP1
foci in wild-type, mTERT
–/– G1 and mTR
–/– G1 MEFs
(Figure 3). We found no signiﬁcant diﬀerence in the
number of phospho-53BP1 foci between wild-type and
mTR
–/– G1 MEFs and in the number of g-H2AX foci
between wild-type and mTERT
–/– G1 MEFs, under
untreated and treated conditions (Figure 3). There was
a small decrease in g-H2AX foci number in mTR
–/– G1
MEFs compared to wild-type (Figure 3B) and in
phospho-53BP1 foci number in mTERT
–/– G1 MEFs
compared to wild-type (Figure 3H), which may be due
to experimental ﬂuctuation. We monitored cell prolifera-
tion by EdU incorporation in treated and untreated
samples. Proliferation was decreased by camptothecin
treatment in the three MEF cultures. Both mTR
–/– G1
and mTERT
–/– G1 MEFs were aﬀected to a similar level
compared to wild-type MEFs (Supplementary Figure S6A
and B). A similar ﬁnding for mTERT
–/– MEFs using
etoposide as a damaging agent was recently reported (49).
Diﬀerent types of genotoxic stress activate diﬀerent
DNA damage response pathways (50). To determine
whether the diﬀerent type of genotoxic stress might
show a diﬀerence in wild-type, mTERT
–/– G1 or mTR
–/–
G1 MEFs, we examined the eﬀect of gamma irradiation
on these cells. We ﬁrst examined the level of damage-
induced protein phosphorylation using western analysis
as described above. When cells were damaged with 5Gy
gamma rays, the phosphorylation of both p53 and H2AX
(g-H2AX) was signiﬁcantly increased in all three cell
cultures (Figure 4). We found no signiﬁcant diﬀerence in
the phosphorylation levels between wild-type, mTERT
–/–
G1 or mTR
–/– G1 MEFs under both untreated (0Gy) and
treated (5Gy) conditions (Figure 4). We next examined
damage-induced foci in response to 5-Gy gamma irradia-
tion. We found a signiﬁcant accumulation of foci
recognized by g-H2AX- and phospho-53BP1 antibodies
in wild-type, mTERT
–/– G1 and mTR
–/– G1 MEFs
(Figure 5). We found no signiﬁcant diﬀerence in the
induction of damage-induced foci between wild-type,
mTERT
–/– G1 and mTR
–/– G1 MEFs under both
untreated and treated conditions. As described above for
camptothecin, cell proliferation was aﬀected by gamma
irradiation to a similar extent in wild-type, mTERT
–/–
G1 and mTR
–/– G1 MEFs (Supplementary Figure S6C
and D). As further evidence that the mTR
–/– and
mTERT
–/– G1 telomerase-null mice have long functional
telomeres, no telomere damage-induced foci (TIFs) (51)
were seen in any of the untreated samples. If any telomeres
in these mice were critically short, we would have seen
TIFs present at telomeres in untreated cells. Overall,
these results indicate that when telomeres are not yet
short in the ﬁrst generation, the absence of either mTR
or mTERT does not alter the cellular response to DNA
damage.
DISCUSSION
Telomeres and telomerase play pivotal roles in cell prolif-
eration, tissue maintenance and the growth of cancer cells.
To fully understand the consequences that telomerase
mutations may have, we set out to examine whether the
absence of mTR or mTERT have an eﬀect on trans-
criptional proﬁles or the DNA damage response. In our
experiments, we found no evidence that, in the setting of
wild-type telomere lengths, telomerase regulates gene
expression or the DNA damage response.
In our expression analysis we used a 2-fold change
as our cut-oﬀ for changes in gene expression. We chose
a 2-fold diﬀerence as a threshold in an attempt to bias in
favor of seeing changes in as many diﬀerentially expressed
genes as possible. Still, we did not ﬁnd any signiﬁcant
changes. In contrast, previous groups found up to a
30-fold diﬀerence in over 600 genes when TERT was
overexpressed (26,27). In our functional assays, using
two diﬀerent types of DNA damage we found that the
DNA damage response was not altered when either
mTR or mTERT were deleted. In a recent paper, similar
results were seen using mTERT
–/– MEFs and ES cells
Nucleic AcidsResearch, 2010,Vol. 38,No. 1 65treated with etoposide and gamma irradiation as a source
of genotoxic damage (49).
Our results stand in contrast to recent reports suggest-
ing that telomerase has telomere length maintenance-
independent roles. Heterologous overexpression of
TERT has been suggested to result in enhancement of
cell proliferation (26), hair follicle stem cell proliferation
(27,28,52), cell survival (24,53) and protection against
apoptosis (24). It has also been suggested that many of
these phenotypes are due to transcriptional induction
of the Wnt pathway (27,41). As described in the
‘Introduction’ section, overexpression of proteins at high
levels can result in neomorphs that have a function which





















































































































































Figure 2. Camptothecin induces a similar DNA damage response in wild-type, mTR
–/– G1 and mTERT
–/– G1 MEFs. The phosphorylation of p53
and H2AX in untreated (DMSO) and cells treated with 5mM camptothecin (CPT) was measured by western blot using phospho-speciﬁc antibodies.
Quantitative graphs show the arithmetic mean and SEM of the expression levels for three replicate experiments. (A) Western blots of cells treated
with camptothecin were probed with a phospho-p53 speciﬁc antibody in wild-type and mTR
–/– G1 MEFs. (B) Normalized phospho-p53 expression
levels: wild-type DMSO compared to mTR
–/– G1 DMSO, P=0.28; wild-type CPT compared to mTR
–/– G1 CPT, P=0.21; wild-type DMSO
compared to wild-type CPT, P=0.005; mTR
–/– G1 DMSO compared to mTR
–/– G1 CPT, P=0.01. (C) Western blots of cells treated with
camptothecin were probed with a phospho-H2AX (g-H2AX) speciﬁc antibody in wild-type and mTR
–/– G1 MEFs. (D) Normalized g-H2AX
expression levels: wild-type DMSO compared to mTR
–/– G1 DMSO, P=0.32; wild-type CPT compared to mTR
–/– G1 CPT, P=0.03; wild-type
DMSO compared to wild-type CPT, P=0.02; mTR
–/– G1 DMSO compared to mTR
–/– G1 CPT, P=0.04. (E) Western blots of cells treated with
camptothecin were probed with a phospho-p53 speciﬁc antibody in wild-type and mTERT
–/– G1 MEFs. (F) Normalized phospho-p53 expression
levels: wild-type DMSO compared to mTERT
–/– G1 DMSO, P=0.19; wild-type CPT compared to mTERT
–/– G1 CPT, P=0.16; wild-type DMSO
compared to wild-type CPT, P=0.002; mTERT
–/– G1 DMSO compared to mTERT
–/– G1 CPT, P=0.001. (G) Western blots of cells treated with
camptothecin were probed with a phospho-H2AX (g-H2AX) speciﬁc antibody in wild-type and mTERT
–/– G1 MEFs. (H) Normalized g-H2AX
expression levels: wild-type DMSO compared to mTERT
–/– G1 DMSO, P=0.69; wild-type CPT compared to mTERT
–/– G1 CPT, P=0.08; wild-
type DMSO compared to wild-type CPT, P=0.037; mTERT
–/– G1 DMSO compared to mTERT
–/– G1 CPT, P=0.005.




































































Figure 3. Camptothecin induces accumulation of g-H2AX and phospho-53BP1 foci in wild-type, mTR
–/– G1 and mTERT
–/– G1 MEFs. g-H2AX
and phospho-53BP1 foci in untreated (DMSO) and cells treated with 5mM camptothecin (CPT) were visualized using immunoﬂuorescence. Repre-
sentative images of each protein and cell line are shown. Quantitative graphs show the fraction of cells that accumulated >10 foci. Graphs show the
arithmetic mean and SEM for three replicate experiments. (A) Immunoﬂuorescence detects camptothecin-induced g-H2AX foci in wild-type and
mTR
–/– G1 MEFs. (B) Quantiﬁcation of cells with >10 g-H2AX foci: wild-type DMSO compared to mTR
–/– G1 DMSO, P=0.18; wild-type CPT
compared to mTR
–/– G1 CPT, P=0.034; wild-type DMSO compared to wild-type CPT, P=0.003; mTR
–/– G1 DMSO compared to mTR
–/– G1
CPT, P=0.002. (C) Immunoﬂuorescence detects camptothecin-induced phospho-53BP1 foci in wild-type and mTR
–/– G1 MEFs. (D) Quantiﬁcation
of cells with >10 phospho-53BP1 foci: wild-type DMSO compared to mTR
–/– G1 DMSO, P=0.23; wild-type CPT compared to mTR
–/– G1 CPT,
P=0.08; wild-type DMSO compared to wild-type CPT, P=0.001; mTR
–/– G1 DMSO compared to mTR
–/– G1 CPT, P=0.05. (E) Immuno-
ﬂuorescence detects camptothecin-induced g-H2AX foci in wild-type and mTERT
–/– G1 MEFs. (F) Quantiﬁcation of cells with >10 g-H2AX foci:
wild-type DMSO compared to mTERT
–/– G1 DMSO, P=0.86; wild-type CPT compared to mTERT
–/– G1 CPT, P=0.75; wild-type DMSO
compared to wild-type CPT, P=0.003; mTERT
–/– G1 DMSO compared to mTERT
–/– G1 CPT, P=0.009. (G) Immunoﬂuorescence detects
camptothecin-induced phospho-53BP1 foci in wild-type and mTERT
–/– G1 MEFs. (H) Quantiﬁcation of cells with >10 phospho-53BP1 foci:
wild-type DMSO compared to mTERT
–/– G1 DMSO, P=0.2; wild-type CPT compared to mTERT
–/– G1 CPT, P=0.02; wild-type DMSO
compared to wild-type CPT, P=0.006; mTERT
–/– G1 DMSO compared to mTERT
–/– G1 CPT, P=0.07.


























































































Figure 4. Gamma irradiation induces a similar DNA damage response in wild-type, mTR
–/– G1 and mTERT
–/– G1 MEFs. The phosphorylation of
p53 and H2AX in untreated (0Gy) and cells treated with 5Gy gamma rays (5Gy) was measured by western blot using phospho-speciﬁc antibodies.
Quantitative graphs show the arithmetic mean and SEM of the expression levels for three replicate experiments. (A) Western blots of cells treated
with gamma rays were probed with a phospho-p53 speciﬁc antibody (arrow) in wild-type and mTR
–/– G1 MEFs. A cross-reacting band was picked
up with this antibody (arrowhead). (B) Normalized phospho-p53 expression levels: wild-type 0Gy compared to mTR
–/– G1 0Gy, P=0.23; wild-type
5Gy compared to mTR
–/– G1 5Gy, P=0.03; wild-type 0Gy compared to wild-type 5Gy, P=0.006; mTR
–/– G1 0Gy compared to mTR
–/– G1
5Gy, P=0.003. (C) Western blots of cells treated with gamma rays were probed with a phospho-H2AX (g-H2AX) speciﬁc antibody in wild-type and
mTR
–/– G1 MEFs. (D) Normalized g-H2AX expression levels: wild-type 0Gy compared to mTR
–/– G1 0Gy, P=0.45; wild-type 5Gy compared to
mTR
–/– G1 5Gy, P=0.54; wild-type 0Gy compared to wild-type 5Gy, P=0.03; mTR
–/– G1 0Gy compared to mTR
–/– G1 5Gy, P=0.007.
(E) Western blots of cells treated with gamma rays were probed with a phospho-p53 speciﬁc antibody (arrow) in wild-type and mTERT
–/– G1 MEFs.
(F) Normalized phospho-p53 expression levels: wild-type 0Gy compared to mTERT
–/– G1 0Gy, P=0.81; wild-type 5Gy compared to mTERT
–/–
G1 5Gy, P=0.37; wild-type 0Gy compared to wild-type 5Gy, P=0.009; mTERT
–/– G1 0Gy compared to mTERT
–/– G1 5Gy, P=0.021.
(G) Western blots of cells treated with gamma rays were probed with a phospho-H2AX (g-H2AX) speciﬁc antibody in wild-type and mTERT
–/–
G1 MEFs. (H) Normalized g-H2AX expression levels: wild-type 0Gy compared to mTERT
–/– G1 0Gy, P=0.23; wild-type 5Gy compared to
mTERT
–/– G1 5Gy, P=0.58; wild-type 0Gy compared to wild-type 5Gy, P=0.025; mTERT
–/– G1 0Gy compared to mTERT
–/– G1 5Gy,
P=0.035.





































































































Figure 5. Gamma irradiation induces accumulation of g-H2AX and phospho-53BP1 foci in wild-type, mTR
–/– G1 and mTERT
–/– G1 MEFs. The
accumulation of g-H2AX and phospho-53BP1 foci in untreated (0Gy) and cells treated with 5Gy gamma rays (5Gy) was visualized using
immunoﬂuorescence. Representative images of each protein and cell line are shown. Quantitative graphs show the fraction of cells that accumulated
>10 foci. Graphs show the arithmetic mean and SEM for three replicate experiments. (A) Immunoﬂuorescence detects gamma ray-induced g-H2AX
foci in wild-type and mTR
–/– G1 MEFs. (B) Quantiﬁcation of cells with >10 g-H2AX foci: wild-type 0Gy compared to mTR
–/– G1 0Gy, P=0.43;
wild-type 5Gy compared to mTR
–/– G1 5Gy, P=1; wild-type 0Gy compared to wild-type 5Gy, P=0.0006; mTR
–/– G1 0Gy compared to mTR
–/–
G1 5Gy, P=0.0007. (C) Immunoﬂuorescence detects gamma ray-induced phospho-53BP1 foci in wild-type and mTR
–/– G1 MEFs. (D) Quantiﬁ-
cation of cells with >10 phospho-53BP1 foci: wild-type 0Gy compared to mTR
–/– G1 0Gy, P=0.12; wild-type 5Gy compared to mTR
–/– G1 5Gy,
P=0.9; wild-type 0Gy compared to wild-type 5Gy, P=0.002; mTR
–/– G1 0Gy compared to mTR
–/– G1 5Gy, P=0.003. (E) Immunoﬂuorescence
detects gamma ray-induced g-H2AX foci in wild-type and mTERT
–/– G1 MEFs. (F) Quantiﬁcation of cells with >10 g-H2AX foci: wild-type 0Gy
compared to mTERT
–/– G1 0Gy, P=0.58; wild-type 5Gy compared to mTERT
–/– G1 5Gy, P=0.15; wild-type 0Gy compared to wild-type 5Gy,
P=0.005; mTERT
–/– G1 0Gy compared to mTERT
–/– G1 5Gy, P=0.002. (G) Immunoﬂuorescence detects gamma ray-induced phospho-53BP1
foci in wild-type and mTERT
–/– G1 MEFs. (H) Quantiﬁcation of cells with >10 phospho-53BP1 foci: wild-type 0Gy compared to mTERT
–/– G1
0Gy, P=0.67; wild-type 5Gy compared to mTERT
–/– G1 5Gy, P=0.89; wild-type 0Gy compared to wild-type 5Gy, P=0.002; mTERT
–/– G1
0Gy compared to mTERT
–/– G1 5Gy, P=0.04.
Nucleic AcidsResearch, 2010,Vol. 38,No. 1 69mice that overexpress speciﬁc proteins are subject to
caveats in the interpretation of the results, in part due to
the creation of neomorphs. The Tet transcriptional
activator used to regulate transgene expression is known
to have functional consequences of its own, and the site of
integration and number of transgenes present can alter the
phenotype (29). Finally, it is known that the Wnt pathway
can be inappropriately activated under a variety of exper-
imental conditions and interpretation of activation is
subject to speciﬁc caveats (54).
In addition to ﬁnding no changes when mTERT was
deleted, we also found no eﬀects when mTR was
deleted. Previous experiments suggested transcriptional
defects from knock-down of mTR (18–20). siRNA
knock-downs may have oﬀ target eﬀects (23,55–57) and
in addition, our results may diﬀer from those previously
reported, due in part to the use of knock-out animals
instead of cancer cell lines. Cancer cell lines are heteroge-
neous and often have very short telomeres (58). In
examining the eﬀects of telomerase component deletion
in cell lines, the possibility of short dysfunctional telo-
meres should be examined, as only a few short telomeres
can induce a DNA damage response (59).
In the experiments presented here we found no evidence
for a role for mTERT or mTR in transcriptional regula-
tion or the DNA damage response. While in our studies
we examined knock-out mice, the results are directly
relevant to human disease. Moreover, genetic anticipation
is observed in mice null for telomerase components
(4,14,15) as well as in families that carry mutant telo-
merase genes (60,61). The study of the telomerase
knock-out mouse thus continues to have relevance for
exploring the role of telomeres and telomerase in disease.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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